“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic

BACKGROUND: Opioid agonist treatment (OAT) improves multiple health and social outcomes, yet requirements to attend for supervised dosing can be burdensome and stigmatising. The COVID-19 pandemic and associated restrictions threatened continuity of care and the wellbeing of people receiving OAT, ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Conway, Anna, Treloar, Carla, Crawford, Sione, Degenhardt, Louisa, Dore, Gregory J, Farrell, Michael, Hayllar, Jeremy, Grebely, Jason, Marshall, Alison D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986137/
https://www.ncbi.nlm.nih.gov/pubmed/36907071
http://dx.doi.org/10.1016/j.drugpo.2023.103998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986137/
https://www.ncbi.nlm.nih.gov/pubmed/36907071
http://dx.doi.org/10.1016/j.drugpo.2023.103998

Ejemplares similares